Ronald Joseph Harbeck, PhD Ask a Question Refer Patient Ronald Joseph Harbeck, PhD, is a researcher at National Jewish Health. Dr. Harbeck is in the Division of Pathology and Department of Medicine. Professor Director, Core and Microbiology Laboratories, ADx Director of Immunology & Beryllium Laboratories Department of Medicine Division of Pathology 5280 Top Doctors 2020 Previously a 5280 Top Doctor America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd. Recognized in America’s Top Doctors — Castle Connolly, Inc. Best Doctors in America® 2019-2020 — Best Doctors, Inc. Recognized in Best Doctors in America® — Best Doctors, Inc. America’s Top Doctors 2020 — Castle Connolly Medical, Ltd. Email Profile Print Profile Overview Contact Info & Locations Programs & Services Department of Medicine Diagnostic Laboratories Division of Pathology Microbiology Laboratory Research Areas Autoimmunity/Rheumatology Pulmonary Disease Research, Other Allergy Asthma Additional Information Ron Harbeck, Ph.D., is Medical Director for the Advanced Diagnostic Laboratories at National Jewish Health. He also oversees operations for the Microbiology and Core Laboratories. His career at National Jewish Health started in 1971, when he was awarded a postdoctoral research fellowship in immunology. More than 40 years later, Dr. Harbeck is still excited about being able to collaborate daily with the institution’s basic scientists and physicians, and is amazed to see the evolutionary development in the Advanced Diagnostic Laboratories’ capabilities and reputation. Dr. Harbeck is actively involved in research and test development. What is fun, he says, is when he starts with something he knows nothing about and over time turns it into a test that ends up helping hundreds of patients. Chronic urticaria is one example. Together with colleagues Drs. Karen Andrews and Donald MacGlashan, Jr., Dr. Harbeck created an immunological test for chronic urticaria, recurrent itchy hives that last for six weeks or longer. Forty percent of chronic urticaria cases have an autoimmune basis, and patients with this form of the condition do not respond to lifestyle modifications often recommended to control the disease. Dr. Harbeck and colleagues invented a method for identifying whether or not autoimmunity is involved with chronic urticaria by detecting the expression of the protein CD203c on cells in the presence of a certain antibody found in chronic urticaria patients. When patients know they have the autoimmune form of chronic urticaria, they can relax their fruitless efforts to change their environment and focus on more beneficial forms of treatment. Dr. Harbeck says that advances in immunology go hand-in-hand with personalized medicine, an exciting paradigm shift in which physicians will increasingly be able to customize treatment based on knowledge of a patient’s genetic profile. As genomic researchers discover mutations, immunological techniques are used to correlate the mutations with abnormalities in cell functioning. Education Education 1971 University of South Dakota (Vermillion, SD), PhD, Microbiology 1964 University of South Dakota (Vermillion, SD), BA, Chemistry Fellowship 1971 - 1973 National Jewish Health, Postdoctoral Research Fellow in Immunology Awards & Recognition 2004: Faculty Good Citizen Award, National Jewish Health 1997: Fellow, American Academy of Microbiology 1988: Fellow, Assoc. of Medical Laboratory Immunologists 1971-1973: NIH Postdoctoral Fellowship, National Jewish Health 1966-1971: NIH Predoctoral Fellowship, Dept of Microbiology, University of South Dakota Board Certification 1979: Board Certification: Diplomate, American Board of Medical Laboratory Immunology, American Academy of Microbiology. Recertification: 1998, 2001, 2004, 2007 and 2010. 1990: New York State Department of Health, Certificate as Laboratory Director 1996: New York State Department of Health, Certificate of Qualification in Cellular and Diagnostic Immunology Professional Memberships American Academy of Allergy, Asthma and Immunology American Society for Microbiology American Association of Immunologists Clinical Immunology Society Association of Medical Laboratory Immunologists (Charter Member) American Association for Clinical Chemistry International Immunocompromised Host Society American Academy of Microbiology Publications Yasnowsky KM, Dreskin SC, Efaw B, Schoen D, Vedanthan PK, Alam R, Harbeck RJ. Chronic Urticaria Sera Increase Basophil CD203c Expression• J Allergy Clin Immunol, 117(6):1430-4, 2006. Armstrong M, Liu AH, Harbeck R, Reisdorph R, Rabinovitch N, Reisdorph N. Leukotriene-E4 in human urine: Comparison of on-line purification and liquid chromatography-tandem mass spectrometry to affinity purification followed by enzyme immunoassay. Journal of Chromatography B Analyt Technol Biomed Life Sci. 877(27):3160-74, 2009. Accetta D, Syverson G, Bonacci B, Reddy S, Bengtson C, Surfus J, Harbeck R, Huttenlocher A, Grossman W, Routes J, Verbsky J. Human phagocyte defect due to Rac2 mutation detected by neonatal screening for T cell lymphopenia. J Allergy Clin Immunol. 2011;127(2):535-538. Milgrom H, Kesler K, Byron M, Harbeck R, Holliday R, Leung DY. Response to cutaneous immunization with low-molecular-weight subunit keyhole limpet hemocyanin (KLH). Int Arch Allergy and Immunol. 157(3):269-274, 2011. Van Dyke MV, Martyny JM, Marola J, Ramamoorthy P, Ridder A, Harbeck RJ, Rose, CS. Efficacy of Occupant-Collected Dust Samples in the Evaluation of Residential Allergen and Fungal Levels. J. Occup Environ Hyg, 9(1):14-24, 2012. Academic Affiliations Professor, Department of Medicine, Division of Allergy & Clinical Immunology, University of Colorado Denver Professor, Integrated Dpartment of Immunology, University of Colorado Denver Website Information Advanced Diagnostic Laboratories Conflicts of Interest National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations. Ask a Question through Patient Portal Sign in to your My National Jewish Health patient portal account to communicate with your care team, manage appointments, and more. Create an Account Contact Information Office: 877.225.5654Fax: 303.270.2125 Locations National Jewish Health Main Campus 1400 Jackson St. Denver, CO 80206 Patient Ratings The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey. This survey is about the patient care experience and does not address crucial characteristics like medical decision-making, prescribing the best therapy, and patient outcomes. Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey. Comments Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.